New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

In the weeks leading up to Dec. 3, I imagined a fantastic headline: “Ozempic treats Alzheimer’s disease.” ...

Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery.

Panelists discuss how the growing prevalence of Alzheimer disease (AD) has created significant clinical, emotional, and ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease.

Researchers have identified elusive DNA switches in brain support cells that influence genes tied to Alzheimer’s disease. When people think about DNA, they often picture genes that determine our ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...

Panelists discuss how APPs adapt their roles to meet the operational needs of their institutions—taking on diagnostic ...